Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780660-26-000002

Chief People Officer sold 4,394 shares at $17.50 ($76,895)

  • Chief People Officer acquired 4,394 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

LO FRANCIS · Chief People Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-22 Exercise or conversion : show line 1 in the form 10b5-1 +1,100 $7.80 $8,580 317,078 D
2025-12-22 Exercise or conversion : show line 2 in the form 10b5-1 +1,100 $8.46 $9,306 318,178 D
2025-12-22 Exercise or conversion : show line 3 in the form 10b5-1 +2,194 $3.99 $8,754 320,372 D
2025-12-22 Sale : show line 4 in the form 10b5-1 −4,394 $17.50 $76,895 315,978 D
Open-market sales · 4,394 sh · avg $17.50 · $76,895

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-12-22 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −1,100 112,150 D
2025-12-22 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −1,100 108,076 D
2025-12-22 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −2,194 107,981 D
Loading xslF345X05/primary_doc.xml…